Wnt/β‑catenin signaling is a novel therapeutic target for tumor suppressor CYLD‑silenced glioblastoma cells.
Kanemaru A, Ito Y, Yamaoka M, Shirakawa Y, Yonemaru K, Miyake S, Ando M, Ota M, Masuda T, Mukasa A, Li JD, Saito H, Hide T, Jono H.
Kanemaru A, et al. Among authors: ota m.
Oncol Rep. 2023 Nov;50(5):201. doi: 10.3892/or.2023.8638. Epub 2023 Sep 29.
Oncol Rep. 2023.
PMID: 37772388